IGF2BP1 and colorectal carcinoma: In contrast, in CRC cells where Wnt signaling is constitutively active, a vast majority of downregulated genes upon β-catenin/Tcf7L2 blockage were found regulated by IGF2BP1, and 17 of these genes were identified as direct binding targets of IGF2BP1.